fig1
Figure 1. The cumulative recurrence rate in patients treated with DAAs after curative treatment for HCC. HCC recurred in 135 patients. The 1-, 2- and 3-year cumulative recurrence rates after DAA therapy were 18%, 39% and 55%, respectively. HCC: hepatocellular carcinoma; DAA: direct-acting antiviral
